Assoc. prof. Takáč Peter, Pharm.D., PhD

Research/art/teacher profile

Date of last update: 01.09.2026

I. Basic information
I.1 Surname
Takáč
I.2 Given name
Peter
I.3 Degrees
Assoc. prof. , Pharm.D., PhD
I.4 Year of birth
1991
I.5 Name of the workplace
University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacology and Toxicology
I.6 Address of the workplace
Komenského 73, 041 81 Košice, Slovak Republic
I.7 Position
associate professor
I.8 E-mail address peter.takac@uvlf.sk
I.9 University staff register / partner university profile https://www.portalvs.sk/regzam/detail/27235
I.10 Study field in which the person works
Pharmacy
I.11 ORCID iD 0009-0004-7732-3323
II. Higher education and further qualification growth
InstitutionYearStudy field and programme
Second degree higher education
University of Veterinary Medicine and Pharmacy in Košice
2015
pharmacy
Third degree higher education
Pavol Jozef Šafárik University in Košice, Faculty of Medicine
2019
medical pharmacology
Habilitation procedure
Faculty of Medicine, UPJŠ in Košice
2024
pharmacology
III. Current and previous employment
OccupationInstitutionYear
Head of the Institue of human and Clinical Pharmacology
University of Veterinary Medicine and Pharmacy in Košice
2019 – 2020
lecturer
University of Veterinary Medicine and Pharmacy in Košice
2018 – 2022
IV. Development of pedagogical, professional, language, digital and other skills
ActivityInstitutionYear
rigorous examination procedure in the field of Pharmacy
University of Veterinary Medicine and Pharmacy in Košice
2018
V. Overview of activities within the teaching career at the university

Academic year: 2026/2027

V.1. Overview of taught profile courses

Profile courseStudy programmeDegreeStudy field
Pharmacology
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Pharmacology I.
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Pharmacology
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Pharmacology II.
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Clinical pharmacology and pharmacotherapy
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Clinical pharmacology and pharmacotherapy
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Pharmacology II.
Pharmacy – full-time study, Slovak language
I. + II.
Pharmacy

V.2. Responsibility for the delivery, development and quality assurance of study programmes

No records yet.

V.3. Responsibility for the development and quality of habilitation and inauguration fields

No records yet.

V.4. Overview of supervised theses

BachelorMasterDoctoral
Currently supervised theses040
Defended theses0270

V.5. Overview of other taught courses

CourseStudy programmeDegreeStudy field
Phytopharmaceuticals
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Clinical pharmacy
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Medicines applied during pregnancy and lactation
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Free radicals and antioxidants
Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language
I. + II.
Pharmacy
Pharmacology I.
Pharmacy – full-time study, Slovak language
I. + II.
Pharmacy
Clinical pharmacy
Pharmacy – full-time study, Slovak language
I. + II.
Pharmacy
Clinical pharmacology and pharmacotherapy
Pharmacy – full-time study, Slovak language
I. + II.
Pharmacy
Free radicals and antioxidants
Pharmacy – full-time study, Slovak language
I. + II.
Pharmacy
VI. Overview of research/artistic/other outputs

The last six completed calendar years: 2020–2025. The current year is excluded.

VI.1. Overview of research/artistic/other outputs and citations

TotalOver the last six years
VI.1.1 Number of research/artistic/other outputs6239
VI.1.2 Number of outputs registered in Web of Science or Scopus1913
VI.1.3 Number of citations corresponding to research/artistic/other outputs357294
VI.1.4 Number of citations registered in Web of Science or Scopus356293
VI.1.5 Number of invited lectures at international and national level00

VI.2. The most significant research/artistic/other outputs

1.
MIKLÁŠOVÁ, Natália - HERICH, Peter - DAVILA-BECERRIL, Juan Carlos - BARROSO-FLORES, Joaquin - FISCHER-FODOR, Eva - VALENTOVÁ, Jindra - LEŠKOVSKÁ, Janka - KOŽÍŠEK, Jozef - TAKÁČ, Peter - MOJŽIŠ, Ján. Evaluation of antiproliferative Palladium(II) complexes of synthetic bisdemethoxycurcumin towards in vitro cytotoxicity and molecular docking on DNA sequence. In: Molecules. 2021. ISSN 1420-3049, Vol. 26, no. 14 (2021), art. no. 4369, p. [1-15]. (2021: 4.927 - IF, 171 - H-index, 5.11 - IF 5y, 0.705 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.671 - ABDC).
2.
TAKÁČ, Peter - KELLO, Martin - VILKOVÁ, Mária - VAŠKOVÁ, Janka - MICHALKOVÁ, Radka - MOJŽIŠOVÁ, Gabriela - MOJŽIŠ, Ján. Antiproliferative effect of acridine chalcone is mediated by induction of oxidative stress. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 2 (2020), art. no. 345, p. [1-19]. (2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q, 1.041 - ABDC).
3.
KELLO, Martin - TAKÁČ, Peter - KUBATKA, Peter - KURUC, Tomáš - PETROVÁ, Klaudia - MOJŽIŠ, Ján. Oxidative stress-induced DNA damage and apoptosis in clove buds-treated MCF-7 cells. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 1 (2020), art. no. 139, p. [1-15]. (2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q, 1.041 - ABDC).
4.
SOKOLI, Libor - TAKÁČ, Peter - BUDOVSKÁ, Mariana - MICHALKOVÁ, Radka - KELLO, Martin - NOSÁLOVÁ, Natália - BALÁŽOVÁ, Ľudmila - SALANCI, Šimon - MOJŽIŠ, Ján. The proapoptotic effect of MB-653 is associated with the modulation of metastasis and invasiveness-related signalling pathways in human colorectal cancer cells. In: Biomolecules. 2025. ISSN 2218-273X, Vol. 15, no. 1 (2025), art. no. 72, p. [1-25]. (2024: 4.8 - IF, 5.6 - IF 5y, 1.333 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 1.152 - ABDC).
5.
TAKÁČ, Peter - MICHALKOVÁ, Radka - ČIŽMÁRIKOVÁ, Martina - BEDLOVIČOVÁ, Zdenka - BALÁŽOVÁ, Ľudmila - TAKÁČOVÁ, Gabriela. The role of silver nanoparticles in the diagnosis and treatment of cancer: Are there any perspectives for the future? In: Life. 2023. ISSN 2075-1729, Vol. 13, no. 2 (2023), art. no. 466, p. [1-44]. (2023: 3.2 - IF, 3.1 - IF 5y, 0.713 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 0.655 - ABDC).

VI.3. The most significant research/artistic/other outputs over the last six years

1.
MIKLÁŠOVÁ, Natália - HERICH, Peter - DAVILA-BECERRIL, Juan Carlos - BARROSO-FLORES, Joaquin - FISCHER-FODOR, Eva - VALENTOVÁ, Jindra - LEŠKOVSKÁ, Janka - KOŽÍŠEK, Jozef - TAKÁČ, Peter - MOJŽIŠ, Ján. Evaluation of antiproliferative Palladium(II) complexes of synthetic bisdemethoxycurcumin towards in vitro cytotoxicity and molecular docking on DNA sequence. In: Molecules. 2021. ISSN 1420-3049, Vol. 26, no. 14 (2021), art. no. 4369, p. [1-15]. (2021: 4.927 - IF, 171 - H-index, 5.11 - IF 5y, 0.705 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.671 - ABDC).
2.
TAKÁČ, Peter - KELLO, Martin - VILKOVÁ, Mária - VAŠKOVÁ, Janka - MICHALKOVÁ, Radka - MOJŽIŠOVÁ, Gabriela - MOJŽIŠ, Ján. Antiproliferative effect of acridine chalcone is mediated by induction of oxidative stress. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 2 (2020), art. no. 345, p. [1-19]. (2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q, 1.041 - ABDC).
3.
KELLO, Martin - TAKÁČ, Peter - KUBATKA, Peter - KURUC, Tomáš - PETROVÁ, Klaudia - MOJŽIŠ, Ján. Oxidative stress-induced DNA damage and apoptosis in clove buds-treated MCF-7 cells. In: Biomolecules. 2020. ISSN 2218-273X, Vol. 10, no. 1 (2020), art. no. 139, p. [1-15]. (2020: 4.879 - IF, 52 - H-index, 5.362 - IF 5y, 1.125 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q, 1.041 - ABDC).
4.
TAKÁČ, Peter - MICHALKOVÁ, Radka - ČIŽMÁRIKOVÁ, Martina - BEDLOVIČOVÁ, Zdenka - BALÁŽOVÁ, Ľudmila - TAKÁČOVÁ, Gabriela. The role of silver nanoparticles in the diagnosis and treatment of cancer: Are there any perspectives for the future? In: Life. 2023. ISSN 2075-1729, Vol. 13, no. 2 (2023), art. no. 466, p. [1-44]. (2023: 3.2 - IF, 3.1 - IF 5y, 0.713 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 0.655 - ABDC).
5.
SOKOLI, Libor - TAKÁČ, Peter - BUDOVSKÁ, Mariana - MICHALKOVÁ, Radka - KELLO, Martin - NOSÁLOVÁ, Natália - BALÁŽOVÁ, Ľudmila - SALANCI, Šimon - MOJŽIŠ, Ján. The proapoptotic effect of MB-653 is associated with the modulation of metastasis and invasiveness-related signalling pathways in human colorectal cancer cells. In: Biomolecules. 2025. ISSN 2218-273X, Vol. 15, no. 1 (2025), art. no. 72, p. [1-25]. (2024: 4.8 - IF, 5.6 - IF 5y, 1.333 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 1.152 - ABDC).

VI.4. The most significant citations corresponding to research/artistic/other outputs

1.
TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292, no. (2018), p. 37-49. (2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.632 - ABDC).
[1] JASIM, Hiba A. - NAHAR, Lutfun - JASIM, Mohammad A. - MOORE, Sharon A. - RITCHIE, Kenneth J. - SARKER, Satyajit D. Chalcones: Synthetic Chemistry Follows Where Nature Leads. In BIOMOLECULES, 2021, vol. 11, no. 8, pp.
2.
TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292, no. (2018), p. 37-49. (2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.632 - ABDC).
[1] KHAMTO, Nopawit - CHAICHUANG, Lada - RITHCHUMPON, Puracheth - PHUPONG, Worrapong - BHOOPONG, Phuangthip - TATEING, Suriya - POMPIMON, Wilart - SEMAKUL, Natthawat - CHOMSRI, Ni-orn - MEEPOWPAN, Puttinan. Synthesis, cytotoxicity evaluation and molecular docking studies on 2 ',4 '-dihydroxy-6 '-methoxy-3 ',5 '-dimethylchalcone derivatives. In RSC ADVANCES, 2021, vol. 11, no. 50, pp. 31433-31447.
3.
TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292, no. (2018), p. 37-49. (2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.632 - ABDC).
[1] KUMAR, Vishal - DHAWAN, Sanjeev - GIRASE, Pankaj Sanjay - AWOLADE, Paul - SHINDE, Suraj Raosaheb - KARPOORMATH, Rajshekhar - SINGH, Parvesh. Recent advances in chalcone-based anticancer heterocycles: A structural and molecular target perspective. In CURRENT MEDICINAL CHEMISTRY. ISSN 0929-8673, 2021, vol. 28, no. 33, pp. 6805-6845.
4.
TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292, no. (2018), p. 37-49. (2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.632 - ABDC).
[1] MESSEHA, Samia S. - ZARMOUH, Najla O. - SOLIMAN, Karam F. A. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer. In NUTRIENTS, 2021, vol. 13, no. 5, pp.
5.
TAKÁČ, Peter - KELLO, Martin - BAGO PILÁTOVÁ, Martina - KUDLIČKOVÁ, Zuzana - VILKOVÁ, Mária - SLEPČÍKOVÁ, Paulína - PETIK, Peter - MOJŽIŠ, Ján. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In: Chemico-Biological Interactions. 2018. ISSN 0009-2797, Vol. 292, no. (2018), p. 37-49. (2018: 3.407 - IF, 115 - H-index, 3.299 - IF 5y, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.632 - ABDC).
[1] SAFWAT, Ghada M. - HASSANIN, Kamel M. A. - MOHAMMED, Eman T. - AHMED, Essam Kh. - ABDEL RHEIM, Mahmoud R. - AMEEN, Mohamed A. - ABDEL-AZIZ, Mohamed - GOUDA, Ahmed M. - PELUSO, Ilaria - ALMEER, Rafa - ABDEL-DAIM, Mohamed M. - ABDEL-WAHAB, Ahmed. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines. In OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. ISSN 1942-0900, 2021, vol. 2021, no., pp. Dostupné na: https://doi.org/10.1155/2021/4759821.

VI.5. Participation in conducting or leading the most important projects over the last six years

1.
Scientific grant agency (Ministry of education, science, research and sport of the Slovak Republic) 1/0166/21 – Effect of combined exposure to neonicotinoid insecticides and azole antifungal agents on selected species of non-target organisms. Project period: 2021–2024.
2.
Scientific grant agency (Ministry of education, science, research and sport of the Slovak Republic) 1/0753/17 – Vplyv prírodných látok na nádorové mikroprostredie. Project period: 2017–2020.
3.
Scientific grant agency (Ministry of education, science, research and sport of the Slovak Republic) 1/0446/22 – Štúdium chalkónov v kontexte ich pôsobenia na membránové transportéry zodpovedné za liekovú rezistenciu. Project period: 2022–2025.
4.
European Structural and Investment Funds 401101B436 – Zriadenie Simulačného centra na UVLF v Košiciach. Project period: 2025–2029.
5.
Scientific grant agency (Ministry of education, science, research and sport of the Slovak Republic) 1/0108/26 – Prospešné baktérie a rastlinné extrakty: sľubná synergia v terapii kožných ochorení koní. Project period: 2026–2029.
VII. Overview of organizational experience related to higher education and research/artistic/other activities
Position / activityInstitutionYear
2025 – to date
2025 – to date
member of Council of the Department of Pharmacology and Toxicology University of veterinary medicine and Pharmacy in Košice
2020 – to date
member of Slovak Medical Association with membership in Pharmacological professional association
2018 – to date
VIII. Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
InstitutionAddressMobility scheme, employment contract, otherYear
2025 – 2025
IX. Other relevant facts
Graduation of the UVLF University Pedagogy course in Košice (September 2024)